Research programme: c-Kit inhibitors - Plexxikon/Phenomix

Drug Profile

Research programme: c-Kit inhibitors - Plexxikon/Phenomix

Alternative Names: c-Kit inhibitors research programme - Plexxikon/Phenomix; PLX 647

Latest Information Update: 05 Mar 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Phenomix Corporation; Plexxikon
  • Class Small molecules
  • Mechanism of Action Macrophage colony stimulating factor receptor antagonists; Proto oncogene protein c-kit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hypersensitivity; Inflammation; Multiple sclerosis; Rheumatoid arthritis

Most Recent Events

  • 05 Mar 2008 Discontinued - Preclinical for Allergy in USA (unspecified route)
  • 05 Mar 2008 Discontinued - Preclinical for Inflammation in USA (unspecified route)
  • 05 Mar 2008 Discontinued - Preclinical for Multiple sclerosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top